What is the mechanism of action for tetracyclines?

What is the mechanism of action for tetracyclines?

• A. Bind 50S ribosomal subunit
• B. Bind 30S subunit and prevent attachment of aminoacyl-tRNA
• C. Inhibit nucleic acid synthesis
• D. Disrupt cell membrane function

Answer: (B)

Tetracyclines work primarily by binding to the 30S ribosomal subunit of bacterial ribosomes. This binding inhibits the attachment of aminoacyl-tRNA to the ribosome during protein synthesis, effectively blocking the addition of new amino acids to the growing peptide chain. This mechanism disrupts the process of translation, preventing the bacteria from producing essential proteins that are required for their growth and reproduction. Because tetracyclines target the translation process specifically at the level of the ribosomal subunit, they are classified as protein synthesis inhibitors. This distinct action is crucial for their efficacy against a wide variety of bacterial infections, including those caused by both Gram-positive and Gram-negative organisms, as well as some atypical bacteria. Other mechanisms listed in the choices involve different types of antibiotics or actions that are not characteristic of tetracyclines. Understanding the specific interaction of tetracyclines with the ribosomal subunit can provide insight into their clinical applications and the potential for antibiotic resistance.

Tetracyclines work primarily by binding to the 30S ribosomal subunit of bacterial ribosomes. This binding inhibits the attachment of aminoacyl-tRNA to the ribosome during protein synthesis, effectively blocking the addition of new amino acids to the growing peptide chain. This mechanism disrupts the process of translation, preventing the bacteria from producing essential proteins that are required for their growth and reproduction.

Because tetracyclines target the translation process specifically at the level of the ribosomal subunit, they are classified as protein synthesis inhibitors. This distinct action is crucial for their efficacy against a wide variety of bacterial infections, including those caused by both Gram-positive and Gram-negative organisms, as well as some atypical bacteria.

Other mechanisms listed in the choices involve different types of antibiotics or actions that are not characteristic of tetracyclines. Understanding the specific interaction of tetracyclines with the ribosomal subunit can provide insight into their clinical applications and the potential for antibiotic resistance.